Nonclinical Safety Evaluation of a Transforming Growth Factor β Receptor I Kinase Inhibitor in Fischer 344 Rats and Beagle Dogs

Anja J Stauber^1*, Kelly M Credille¹, Lewis L Truex¹, William J Ehlhardt¹ and Jamie K Young²

¹Lilly Research Laboratories, Toxicology and Pathology, Eli Lilly and Company, Indianapolis, IN, 46285, USA

²Covance Laboratories Inc., Greenfield, Indiana, 46140, USA

^*Corresponding Author: Anja J Stauber, Lilly Corporate CenterEli Lilly and Company, Indianapolis, Indiana 46285, USA, Tel: 317-433-9486 Email: